These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8930935

  • 1. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
    Hatzinger M, Reul JM, Landgraf R, Holsboer F, Neumann I.
    Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
    [Abstract] [Full Text] [Related]

  • 2. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS.
    J Endocrinol Invest; 1997 Nov; 20(7):393-6. PubMed ID: 9309537
    [Abstract] [Full Text] [Related]

  • 3. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [Abstract] [Full Text] [Related]

  • 4. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 5. Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats.
    Hatzinger M, Wotjak CT, Naruo T, Simchen R, Keck ME, Landgraf R, Holsboer F, Neumann ID.
    J Endocrinol; 2000 Feb; 164(2):197-205. PubMed ID: 10657855
    [Abstract] [Full Text] [Related]

  • 6. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs.
    Rothuizen J, Reul JM, van Sluijs FJ, Mol JA, Rijnberk A, de Kloet ER.
    Endocrinology; 1993 Jan; 132(1):161-8. PubMed ID: 8380372
    [Abstract] [Full Text] [Related]

  • 7. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.
    Keck ME, Wigger A, Welt T, Müller MB, Gesing A, Reul JM, Holsboer F, Landgraf R, Neumann ID.
    Neuropsychopharmacology; 2002 Jan; 26(1):94-105. PubMed ID: 11751036
    [Abstract] [Full Text] [Related]

  • 8. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone.
    Kamphuis PJ, Bakker JM, Broekhoven MH, Kunne C, Croiset G, Lentjes EG, Tilders FJ, van Bel F, Wiegant VM.
    Neuroendocrinology; 2002 Sep; 76(3):158-69. PubMed ID: 12218348
    [Abstract] [Full Text] [Related]

  • 9. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA, Yu C, Stelzl GE, Weinberg J.
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [Abstract] [Full Text] [Related]

  • 10. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
    Buwalda B, de Boer SF, Schmidt ED, Felszeghy K, Nyakas C, Sgoifo A, Van der Vegt BJ, Tilders FJ, Bohus B, Koolhaas JM.
    J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
    [Abstract] [Full Text] [Related]

  • 11. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I, Yassouridis A, Holsboer F.
    J Psychiatr Res; 1994 Jul; 28(4):341-56. PubMed ID: 7877114
    [Abstract] [Full Text] [Related]

  • 12. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 13. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment.
    Felszeghy K, Bagdy G, Nyakas C.
    J Neuroendocrinol; 2000 Oct; 12(10):1014-21. PubMed ID: 11012843
    [Abstract] [Full Text] [Related]

  • 14. Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary adrenal axis in the rat.
    Bakker JM, Schmidt ED, Kroes H, Kavelaars A, Heijnen CJ, Tilders FJ, van Rees EP.
    J Neuroimmunol; 1995 Dec 31; 63(2):183-91. PubMed ID: 8550816
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS.
    Metabolism; 1994 May 31; 43(5):544-8. PubMed ID: 8177041
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y, Aguilera G.
    Neuroendocrinology; 1992 Nov 31; 56(5):611-8. PubMed ID: 1336816
    [Abstract] [Full Text] [Related]

  • 17. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
    van der Meer MJ, Sweep CG, Pesman GJ, Tilders FJ, Hermus AR.
    Cytokine; 1996 Dec 31; 8(12):910-9. PubMed ID: 9050749
    [Abstract] [Full Text] [Related]

  • 18. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L.
    ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
    [Abstract] [Full Text] [Related]

  • 19. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 31; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 20. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 31; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.